Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Bone and Mineral Metabolism
Published in: Journal of Bone and Mineral Metabolism 1/2005

01-01-2005 | CASE REPORT

Trochanteric hip fracture in an elderly patient with leprosy during osteoporosis treatment with risedronate and alfacalcidol

Authors: Arihiko Kanaji, Masaaki Higashi, Masako Namisato, Kenichi Ando, Masato Nakagawa, Yoshiyuki Yato, Hirofusa Ichinose, Toyonori Sakamaki, Harumoto Yamada

Published in: Journal of Bone and Mineral Metabolism | Issue 1/2005

Login to get access
Metadata
Title
Trochanteric hip fracture in an elderly patient with leprosy during osteoporosis treatment with risedronate and alfacalcidol
Authors
Arihiko Kanaji
Masaaki Higashi
Masako Namisato
Kenichi Ando
Masato Nakagawa
Yoshiyuki Yato
Hirofusa Ichinose
Toyonori Sakamaki
Harumoto Yamada
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Journal of Bone and Mineral Metabolism / Issue 1/2005
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-004-0546-7

Other articles of this Issue 1/2005

Journal of Bone and Mineral Metabolism 1/2005 Go to the issue

ORIGINAL ARTICLE

The relationships between pubertal development, IGF-1 axis, and bone formation in healthy adolescents

EDITORIAL

EDITORIAL

ORIGINAL ARTICLE

Bone mineral and soft-tissue changes in AIDS-associated lipoatrophy

ORIGINAL ARTICLE

Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis

ORIGINAL ARTICLE

Association of estrogen receptor-α gene polymorphisms with bone mineral density in postmenopausal Korean women

ORIGINAL ARTICLE

Vitamin K2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG)
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits